BNP Paribas Financial Markets’s Acer Therapeutics Inc ACER Stock Holding History

BNP Paribas Financial Markets’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-179	Closed	-$449	–	4102
2022 Q4	$449	Hold	179	–	–	﹤0.01%	3870
2022 Q3	$249	Hold	179	–	–	﹤0.01%	4592
2022 Q2	$226	Hold	179	–	–	﹤0.01%	3989
2022 Q1	$519	Hold	179	–	–	﹤0.01%	4016
2021 Q4	$412	Hold	179	–	–	﹤0.01%	4123
2021 Q3	$456	Hold	179	–	–	﹤0.01%	3927
2021 Q2	$512	Hold	179	–	–	﹤0.01%	3980
2021 Q1	$557	Hold	179	–	–	﹤0.01%	3938
2020 Q4	$469	Hold	179	–	–	﹤0.01%	4047
2020 Q3	$516	Sell	179 -9,951	-98%	-$32.2K	﹤0.01%	4104
2020 Q2	$34.7K	Buy	10,130 +8,579	+553%	+$24.2K	﹤0.01%	3179
2020 Q1	$3.09K	Buy	1,551 +851	+122%	+$3.12K	﹤0.01%	4105
2019 Q4	$2.81K	Buy	700 +452	+182%	+$1.54K	﹤0.01%	4204
2019 Q3	$791	Buy	248 +235	+1,808%	+$689	﹤0.01%	4410
2019 Q2	$51	Buy	+13	New	+$248	﹤0.01%	4494

Other funds holding ACER

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MWM

Meridian Wealth Management Lexington, Kentucky $3.25B AUM 41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets's ACER Position: Q1 2023 in Review

BNP Paribas Financial Markets sold out of Acer Therapeutics Inc (ACER) in Q1 2023, closing a stake of 179 shares — an estimated $449 sold.

BNP Paribas Financial Markets first reported a position in ACER in Q2 2019 and held it in 15 quarters. The position peaked at $34.7K in Q2 2020. 27 funds tracked by Wall St. Rank hold ACER as of Q1 2023.

BNP Paribas Financial Markets reported no remaining Acer Therapeutics Inc position as of Q1 2023 after selling out during the quarter.
BNP Paribas Financial Markets sold 179 Acer Therapeutics Inc shares in Q1 2023, an estimated $449.
BNP Paribas Financial Markets first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 15 quarters.
BNP Paribas Financial Markets's Acer Therapeutics Inc position peaked at $34.7K in Q2 2020.
27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.